Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,279 | 174 | 92.1% |
| Education | $279.65 | 8 | 7.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $538.06 | 34 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $404.20 | 20 | $0 (2024) |
| GlaxoSmithKline, LLC. | $386.64 | 24 | $0 (2024) |
| Lilly USA, LLC | $331.41 | 14 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $306.39 | 17 | $0 (2022) |
| Medtronic USA, Inc. | $296.41 | 10 | $0 (2019) |
| Astellas Pharma US Inc | $260.36 | 8 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $160.94 | 4 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $116.97 | 7 | $0 (2019) |
| Merck Sharp & Dohme LLC | $103.30 | 6 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $336.17 | 18 | Novo Nordisk Inc ($92.77) |
| 2023 | $519.48 | 25 | GlaxoSmithKline, LLC. ($156.47) |
| 2022 | $338.46 | 20 | GlaxoSmithKline, LLC. ($82.55) |
| 2021 | $462.16 | 28 | Novo Nordisk Inc ($186.56) |
| 2020 | $192.39 | 11 | AstraZeneca Pharmaceuticals LP ($73.62) |
| 2019 | $697.43 | 32 | Medtronic USA, Inc. ($199.34) |
| 2018 | $657.45 | 26 | Boehringer Ingelheim Pharmaceuticals, Inc. ($131.73) |
| 2017 | $355.37 | 22 | Novo Nordisk Inc ($76.20) |
All Payment Transactions
182 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: Gastroenterology | ||||||
| 12/02/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $19.59 | General |
| Category: Diabetes Care | ||||||
| 11/21/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.65 | General |
| Category: Cardio-renal | ||||||
| 11/21/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: Diabetes | ||||||
| 11/18/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: Diabetes | ||||||
| 10/24/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.56 | General |
| Category: Cardio-renal | ||||||
| 10/16/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: Diabetes Care | ||||||
| 08/31/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.42 | General |
| Category: Diabetes | ||||||
| 08/08/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.84 | General |
| Category: Diabetes | ||||||
| 08/05/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $24.01 | General |
| Category: Diabetes Care | ||||||
| 07/12/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: Diabetes | ||||||
| 07/11/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: Diabetes | ||||||
| 06/20/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/07/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $19.43 | General |
| Category: PAIN MANAGEMENT | ||||||
| 05/30/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.47 | General |
| Category: Diabetes | ||||||
| 05/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.69 | General |
| Category: Diabetes | ||||||
| 03/11/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: RESPIRATORY | ||||||
| 03/07/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: Oncology | ||||||
| 11/14/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $13.51 | General |
| Category: VACCINES | ||||||
| 11/02/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.86 | General |
| Category: Diabetes | ||||||
| 10/20/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: Diabetes | ||||||
| 10/18/2023 | Radius Health, Inc. | Tymlos (Drug) | Education | In-kind items and services | $15.80 | General |
| Category: Endocrinology | ||||||
| 10/18/2023 | Radius Health, Inc. | Tymlos (Drug) | Education | In-kind items and services | $15.80 | General |
| Category: Endocrinology | ||||||
| 10/18/2023 | Radius Health, Inc. | Tymlos (Drug) | Education | In-kind items and services | $15.80 | General |
| Category: Endocrinology | ||||||
| 10/18/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.83 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 34 | 2,966 | 5,221 | $455,090 | $251,600 |
| 2022 | 42 | 4,213 | 7,344 | $656,230 | $373,595 |
| 2021 | 42 | 4,524 | 7,882 | $644,111 | $380,147 |
| 2020 | 35 | 5,120 | 10,106 | $824,954 | $391,498 |
All Medicare Procedures & Services
153 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 382 | 883 | $123,620 | $73,804 | 59.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 409 | 1,222 | $134,420 | $66,768 | 49.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 249 | 249 | $37,350 | $30,771 | 82.4% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 84 | 98 | $28,420 | $19,992 | 70.3% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 266 | 271 | $32,520 | $19,833 | 61.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 44 | 54 | $10,800 | $6,749 | 62.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 333 | 634 | $9,510 | $5,326 | 56.0% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2023 | 131 | 137 | $8,220 | $4,564 | 55.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 124 | 130 | $5,140 | $3,836 | 74.6% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 81 | 98 | $7,350 | $3,393 | 46.2% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 55 | 120 | $4,200 | $1,946 | 46.3% |
| 96130 | Evaluation of psychological test, first hour | Office | 2023 | 23 | 23 | $2,875 | $1,624 | 56.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 81 | 178 | $5,340 | $1,596 | 29.9% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 92 | 133 | $6,650 | $1,266 | 19.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 13 | 13 | $2,340 | $963.94 | 41.2% |
| 99348 | Residence visit for established patient with low level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 22 | 30 | $3,300 | $959.29 | 29.1% |
| 93922 | Ultrasound study of arm and leg arteries | Office | 2023 | 17 | 17 | $2,550 | $954.30 | 37.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 25 | 25 | $3,250 | $946.81 | 29.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 88 | 97 | $5,820 | $932.11 | 16.0% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 21 | 21 | $1,470 | $862.77 | 58.7% |
| 0134A | Adm sarscv2 bvl 50mcg/.5ml a | Office | 2023 | 19 | 19 | $760.00 | $744.80 | 98.0% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 49 | 53 | $1,325 | $695.36 | 52.5% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 18 | 19 | $1,235 | $579.84 | 47.0% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 12 | 13 | $1,040 | $534.30 | 51.4% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 24 | 24 | $600.00 | $388.80 | 64.8% |
About Dr. Pedro Penalo, MD
Dr. Pedro Penalo, MD is a Internal Medicine healthcare provider based in Weslaco, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1104920859.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Pedro Penalo, MD has received a total of $3,559 in payments from pharmaceutical and medical device companies, with $336.17 received in 2024. These payments were reported across 182 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($3,279).
As a Medicare-enrolled provider, Penalo has provided services to 16,823 Medicare beneficiaries, totaling 30,553 services with total Medicare billing of $1.4M. Data is available for 4 years (2020–2023), covering 153 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Weslaco, TX
- Active Since 09/12/2006
- Last Updated 10/30/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1104920859
Products in Payments
- XARELTO (Drug) $330.61
- JARDIANCE (Drug) $295.63
- Ozempic (Drug) $279.49
- NUVENT (Device) $253.57
- FARXIGA (Drug) $244.28
- TRELEGY ELLIPTA (Drug) $148.36
- Victoza (Drug) $116.27
- TRULICITY (Drug) $115.38
- AREXVY (Drug) $95.55
- MYRBETRIQ (Drug) $81.35
- RYBELSUS (Drug) $72.35
- JANUVIA (Drug) $69.19
- Vascepa (Drug) $65.82
- SHINGRIX (Biological) $65.22
- Kerendia (Drug) $62.25
- FREESTYLE LIBRE 3 (Device) $62.14
- XIFAXAN (Drug) $56.79
- INVOKANA (Drug) $52.44
- TOUJEO (Drug) $49.23
- BYDUREON (Drug) $48.61
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Weslaco
Hector Amaya Chinchilla, M.d, M.D
Internal Medicine — Payments: $5,736
Dionisio Calvo
Internal Medicine — Payments: $4,184
Dr. Claudia Pierson, M.d, M.D
Internal Medicine — Payments: $3,969
Dr. Robert Sepulveda, M.d, M.D
Internal Medicine — Payments: $2,673
Jesus Rodriguez Hernandez, M.d, M.D
Internal Medicine — Payments: $2,593
Dr. Amrit Sraow, M.d, M.D
Internal Medicine — Payments: $1,916